Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
Summary
- Eligibility
- for females ages 18-50 (full criteria)
- Location
- at UCLA
- Dates
- study startedstudy ends around
- Principal Investigator
- by Steve Raman, MD (ucla)
Description
Summary
Details
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Steve Raman, MD (ucla)
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- InSightec
- ID
- NCT05386615
- Study Type
- Observational [Patient Registry]
- Participants
- Expecting 200 study participants
- Last Updated